Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-111721
Filing Date
2020-10-02
Accepted
2020-10-02 16:30:14
Documents
1
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2032337-1_3.html 3  
1 OWNERSHIP DOCUMENT tm2032337-1_3.xml 3 5963
  Complete submission text file 0001104659-20-111721.txt   8577
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Issuer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Reporting) CIK: 0001346824 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35558 | Film No.: 201220427

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address
Kolchinsky Peter (Reporting) CIK: 0001384859 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35558 | Film No.: 201220426

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address
Shah Rajeev M. (Reporting) CIK: 0001619841 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35558 | Film No.: 201220425